ArticleOncogene2012
The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells.
M Durán-Prado et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papertrialcites it